130 related articles for article (PubMed ID: 2988337)
1. Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection.
Barlow JJ; Lele SB; Emrich LJ
Am J Obstet Gynecol; 1985 Jun; 152(3):310-4. PubMed ID: 2988337
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of ovarian cancer. New approaches to treatment.
Smith JP; Rutledge F; Wharton JT
Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
[No Abstract] [Full Text] [Related]
4. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
Poon MA; O'Connell MJ; Moertel CG; Wieand HS; Cullinan SA; Everson LK; Krook JE; Mailliard JA; Laurie JA; Tschetter LK
J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in the treatment of cancer of the ovary.
Smith JP; Rutledge F
Am J Obstet Gynecol; 1970 Jul; 107(5):691-703. PubMed ID: 4316665
[No Abstract] [Full Text] [Related]
6. Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin.
Park RC; Blom J; Disaia PJ; Lagasse LD; Blessing JA
Cancer; 1980 May; 45(10):2529-42. PubMed ID: 7378989
[TBL] [Abstract][Full Text] [Related]
7. Treatment and immunodiagnosis of advanced ovarian adenocarcinoma: a preliminary report.
Piver MS; Barlow JJ; Bhattacharya M
Cancer Treat Rep; 1979 Feb; 63(2):265-7. PubMed ID: 376133
[TBL] [Abstract][Full Text] [Related]
8. [Effect of chemotherapy on the prognosis of ovarian cancer].
Sugawa T; Umesaki N; Yajima A; Satoh S; Terashima Y; Ochiai K; Tomoda Y; Kanoh T; Noda K; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1135-41. PubMed ID: 1333504
[TBL] [Abstract][Full Text] [Related]
9. The use of Fluorouracil (5-FU) and leucovorin in women with heavily pretreated advanced ovarian carcinoma.
Peled Y; Levavi H; Krissi H; Weill Y; Sabah G; Eitan R
Am J Clin Oncol; 2013 Oct; 36(5):472-4. PubMed ID: 22706176
[TBL] [Abstract][Full Text] [Related]
10. High-dose methotrexate with "RESCUE" plus cyclophosphamide as initial chemotherapy in ovarian adenocarcinoma. A randomized trial with observations on the influence of C parvum immunotherapy.
Barlow JJ; Piver MS; Lele SB
Cancer; 1980 Sep; 46(6):1333-8. PubMed ID: 6998553
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
Valone FH; Friedman MA; Wittlinger PS; Drakes T; Eisenberg PD; Malec M; Hannigan JF; Brown BW
J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
[TBL] [Abstract][Full Text] [Related]
13. Clinical remission criteria for epithelial carcinoma of the ovary.
Morikawa Y; Kawai M; Kano T; Kikkawa F; Oguchi H; Nakashima N; Ishizuka T; Furuhashi Y; Hattori SE; Kuzuya K
Gynecol Oncol; 1993 Mar; 48(3):342-8. PubMed ID: 7681806
[TBL] [Abstract][Full Text] [Related]
14. Comparison of melphalan with cyclophosphamide, methotrexate, and 5-fluorouracil in patients with ovarian cancer.
Brodovsky HS; Bauer M; Horton J; Elson PJ
Cancer; 1984 Feb; 53(4):844-52. PubMed ID: 6546359
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients.
Brower MS; Coleman M; Pasmantier MW; Silver RT; Mamaril AP; Quiguyan CC
Med Pediatr Oncol; 1984; 12(1):17-24. PubMed ID: 6321930
[TBL] [Abstract][Full Text] [Related]
16. Metastatic ovarian cancer.
Smith JP; Rutledge FN
Clin Obstet Gynecol; 1973 Jun; 16(2):286-97. PubMed ID: 4351522
[No Abstract] [Full Text] [Related]
17. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
Bruckner HW; Dinse GE; Davis TE; Falkson G; Creech RH; Arseneau JC; Greenspan EM; Brodovsky HS; Pagano M; Hahn RG
Cancer; 1985 Jan; 55(1):26-40. PubMed ID: 3917352
[TBL] [Abstract][Full Text] [Related]
19. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
20. Etoposide (VP-16) plus cisplatin (DDP): a new active chemotherapeutic combination in patients with stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
J Surg Oncol; 1986 May; 32(1):43-5. PubMed ID: 3724190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
